Warm congratulations!
On January 27, 2022, the registration application of the innovative product "Abdominal Endoscopic Surgery System" produced by Shanghai MicroPort MedBot (Group) Co., Ltd. was approved by NMPA.Links Medical Scientific (Shanghai) Co., Ltd.participated in the pre-market research of the system.
The product is composed of doctor console, patient operation platform, image platform, three-dimensional electronic endoscope, endoscope image processor, passive surgical instruments, high-frequency surgical instruments and accessories. Doctors use the master-slave control system to control the minimally invasive surgical instruments for laparoscopic surgery in urology. Its advantage is that it can improve the operation quality and ensure the safety of operation. Compared with imported products, it will greatly reduce the treatment cost and reduce the economic burden of patients.
LINKS CRO
As a CRO company providing clinical trial services. LINKS CRO focus on innovation, high-risk implantation(intervention) medical device, with one-stop clinical trial solutions for the whole process of medical device research and development.The headquarters of LINKS is based in Shanghai, with subsidiary branches in Beijing, Shanghai, Guangzhou, and Shenzhen, in addition to ten regional offices. The current workforce comprises almost 200 employees, with technical personnel making up over 85% and dispersed across almost 30 cities nationwide.
Key Services include CRO, SMO, CER, Audit, Post-market research, core laboratory registration both domestically and overseas, innovation declaration, Expert Consultancy, and overseas enterprise agency services.
Key Indications include Cardiovascular, Neurovascular, Peripheral Vascular, Surgery Robot, Oncology, Ophthalmology, Medical Cosmetology, and other fields such as orthopedics. There are almost 300 projects consultations and services by LINKS each year.
